Literature DB >> 31911761

Isolated Right Ventricular Metastasis in a Woman with Advanced Hepatocellular Carcinoma after Palliative Therapy.

Chun-Ting Fan1, Wei-Wen Lin2,3, Ming-Jer Chen1,4, Sz-Iuan Shiu5,6,7.   

Abstract

Hepatocellular carcinoma (HCC) with cardiac metastasis represents a group of rarity and poor prognosis. Few case reports have described this patient entity, and it remains unclear regarding the optimal treatment and predicted outcome for these patients. In our case, we represented a 67-year-old female patient with presentations of dyspnea and heart murmur, which conducted to the diagnosis of advanced HCC with isolated right ventricular metastasis. Because of multiple comorbidities regarding cardiac and pulmonary systems, she received best supportive care and survived 2 months after initial diagnosis. A systemic literature review of 80 published cases (including our patient) since the 1950s was also performed from PubMed, and the data were gathered from the medical record and literature reviews. In our review, patients with advanced HCC and cardiac metastasis involved the right heart mainly with a predominance of right atrium (53%). Meanwhile the overall 3-month survival rate in our review was 70.7%. In subgroup analysis, the overall 3-month survival was highest (97%) in patients treated with surgery and other therapies, and lowest (27%) in patients with best supportive care. To our knowledge, this is the first comprehensive literature review addressing the epidemiology, optimal treatment, and prognosis for advanced-stage HCC with cardiac metastasis. We suggest that abnormal cardiac murmur in patients with history of HCC should prompt investigation for tumor involvement of the heart. We also emphasize individualized treatment as well as prognostic measurement accordingly.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Advanced hepatocellular carcinoma; Cardiac metastasis; Case report

Year:  2019        PMID: 31911761      PMCID: PMC6940437          DOI: 10.1159/000504566

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


  12 in total

1.  AASLD guidelines for the treatment of hepatocellular carcinoma.

Authors:  Julie K Heimbach; Laura M Kulik; Richard S Finn; Claude B Sirlin; Michael M Abecassis; Lewis R Roberts; Andrew X Zhu; M Hassan Murad; Jorge A Marrero
Journal:  Hepatology       Date:  2018-01       Impact factor: 17.425

Review 2.  Outcomes of surgery for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium.

Authors:  Kazuhiko Sakamoto; Hiroaki Nagano
Journal:  Surg Today       Date:  2017-12-26       Impact factor: 2.549

Review 3.  EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

Authors: 
Journal:  J Hepatol       Date:  2018-04-05       Impact factor: 25.083

4.  Prognosis of untreated hepatocellular carcinoma.

Authors:  Edoardo G Giannini; Fabio Farinati; Francesca Ciccarese; Anna Pecorelli; Gian Lodovico Rapaccini; Mariella Di Marco; Luisa Benvegnù; Eugenio Caturelli; Marco Zoli; Franco Borzio; Maria Chiaramonte; Franco Trevisani
Journal:  Hepatology       Date:  2014-11-26       Impact factor: 17.425

5.  Extrahepatic metastases of hepatocellular carcinoma.

Authors:  S Katyal; J H Oliver; M S Peterson; J V Ferris; B S Carr; R L Baron
Journal:  Radiology       Date:  2000-09       Impact factor: 11.105

Review 6.  Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.

Authors:  Yan Zhao; Guohong Cai; Lin Zhou; Lei Liu; Xingshun Qi; Ming Bai; Yongping Li; Daiming Fan; Guohong Han
Journal:  Asia Pac J Clin Oncol       Date:  2013-05-29       Impact factor: 2.601

Review 7.  Extrahepatic metastases of hepatocellular carcinoma: A spectrum of imaging findings.

Authors:  Annalisa K Becker; David K Tso; Alison C Harris; David Malfair; Silvia D Chang
Journal:  Can Assoc Radiol J       Date:  2013-11-13       Impact factor: 2.248

Review 8.  Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival.

Authors:  Josep M Llovet; Jordi Bruix
Journal:  Hepatology       Date:  2003-02       Impact factor: 17.425

9.  Clinically Silent Intracardiac Metastasis with Extremely Poor Prognosis in a Patient with Hepatocellular Carcinoma.

Authors:  Mashal Salehi; The Yee; Eric Alatevi; Yamin Thein
Journal:  Case Rep Gastroenterol       Date:  2017-07-11

10.  Transcatheter arterial chemoembolization after stopping sorafenib therapy for advanced hepatocellular carcinoma.

Authors:  Yao-Kuang Huang; Chieh-Ling Yen; Sz-Iuan Shiu; Shou-Wu Lee; Pi-Yi Chang; Hong-Zen Yeh; Teng-Yu Lee
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.